ClinicalTrials.gov
ClinicalTrials.gov Menu

Lenalidomide and Paclitaxel in Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01155505
Recruitment Status : Unknown
Verified September 2011 by Southern Europe New Drug Organization.
Recruitment status was:  Active, not recruiting
First Posted : July 1, 2010
Last Update Posted : September 13, 2011
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Southern Europe New Drug Organization

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2011
  Estimated Study Completion Date : March 2012